BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS SALVAGE THERAPY FOR SPLENIC MARGINAL ZONE LYMPHOMA
- Autori: Iannitto, E; Mancuso, S; Augello, A; Franco, G; Domingo Domenech, E; Pennese, E; Vincenzo, V
- Anno di pubblicazione: 2010
- Tipologia: eedings
- OA Link: http://hdl.handle.net/10447/75027
Abstract
At present, a prospectively validated treatment for SMZL is lacking. Despite this fact, splenectomy is still deemed to be the best choice for patients requiring treatment. Nevertheless, the high fraction of patients achieving a clinical response following splenectomy eventually relapses or progresses